Sudeep Pharma Board of Directors

Get the latest insights into the leadership at Sudeep Pharma. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Sujit Jaysukh BhayaniChairman & Managing Director
Shanil Sujit BhayaniWhole Time Director
Ajay Shrirang KandelkarWhole Time Director
Raghunandan Sathyanarayan RaoNon Executive Independent Director
Reshma PatelNon Executive Independent Director
Samaresh ParidaNon Executive Independent Director
Sujit GulatiNon Executive Independent Director
Dimple MehtaCompany Secretary & Compliance Officer

Sudeep Pharma Share price

SUDEEPPHRM

681.8

6.15 (-0.89%)
NSE
BSE
Last updated on 24 Apr, 2026 | 15:49 IST
Today's High

707.00

Today's Low

678.00

52 Week Low

524.05

52 Week High

795.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Sudeep Pharma FAQs

The board at Sudeep Pharma consists of experienced professionals, including Sujit Jaysukh Bhayani, Shanil Sujit Bhayani, and others, overseeing the company’s strategic and corporate governance.

Directors at Sudeep Pharma are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Sujit Jaysukh Bhayani is the current chairman at Sudeep Pharma.

Executive directors at Sudeep Pharma are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Sudeep Pharma adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Sudeep Pharma, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost